Citadel Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $369M | Buy |
1,869,793
+1,449,726
| +345% | +$280M | 0.06% | 251 |
|
|
2025
Q4 | $77.2M | Sell |
420,067
-1,373,076
| -77% | -$241M | 0.01% | 1048 |
|
|
2025
Q3 | $275M | Buy |
1,793,143
+877,671
| +96% | +$133M | 0.04% | 356 |
|
|
2025
Q2 | $128M | Sell |
915,472
-107,639
| -11% | -$15.1M | 0.02% | 609 |
|
|
2025
Q1 | $150M | Sell |
1,023,111
-1,088,298
| -52% | -$157M | 0.03% | 479 |
|
|
2024
Q4 | $277M | Buy |
2,111,409
+1,887,183
| +842% | +$264M | 0.05% | 283 |
|
|
2024
Q3 | $34.9M | Sell |
224,226
-84,628
| -27% | -$13.7M | 0.01% | 1534 |
|
|
2024
Q2 | $48.2M | Buy |
308,854
+64,428
| +26% | +$9.7M | 0.01% | 1182 |
|
|
2024
Q1 | $33.1M | Buy |
244,426
+29,865
| +14% | +$3.95M | 0.01% | 1565 |
|
|
2023
Q4 | $28.9M | Sell |
214,561
-172,339
| -45% | -$22.4M | 0.01% | 1659 |
|
|
2023
Q3 | $52.4M | Buy |
386,900
+71,201
| +23% | +$9.72M | 0.01% | 1038 |
|
|
2023
Q2 | $45.2M | Buy |
315,699
+140,197
| +80% | +$20.6M | 0.01% | 1129 |
|
|
2023
Q1 | $24.4M | Buy |
175,502
+17,900
| +11% | +$2.41M | 0.01% | 1731 |
|
|
2022
Q4 | $21.4M | Sell |
157,602
-662,728
| -81% | -$83.1M | 0.01% | 1899 |
|
|
2022
Q3 | $90M | Buy |
820,330
+813,738
| +12,344% | +$103M | 0.02% | 658 |
|
|
2022
Q2 | $871K | Sell |
6,592
-2,146
| -25% | -$282K | ﹤0.01% | 7338 |
|
|
2022
Q1 | $1.16M | Sell |
8,738
-579,477
| -99% | -$69.5M | ﹤0.01% | 7373 |
|
|
2021
Q4 | $68.5M | Buy |
588,215
+103,029
| +21% | +$12.1M | 0.01% | 932 |
|
|
2021
Q3 | $58.3M | Sell |
485,186
-131,160
| -21% | -$15.3M | 0.01% | 1008 |
|
|
2021
Q2 | $73.8M | Sell |
616,346
-573,472
| -48% | -$62.9M | 0.02% | 849 |
|
|
2021
Q1 | $118M | Sell |
1,189,818
-703,022
| -37% | -$70.7M | 0.03% | 512 |
|
|
2020
Q4 | $189M | Buy |
1,892,840
+1,475,339
| +353% | +$156M | 0.05% | 279 |
|
|
2020
Q3 | $45.8M | Sell |
417,501
-47,345
| -10% | -$5.27M | 0.01% | 917 |
|
|
2020
Q2 | $49.2M | Sell |
464,846
-424,526
| -48% | -$43.8M | 0.02% | 810 |
|
|
2020
Q1 | $79.4M | Buy |
889,372
+641,279
| +258% | +$60.4M | 0.04% | 430 |
|
|
2019
Q4 | $24.7M | Sell |
248,093
-509,376
| -67% | -$48M | 0.01% | 1294 |
|
|
2019
Q3 | $67.5M | Buy |
757,469
+113,587
| +18% | +$9.85M | 0.03% | 590 |
|
|
2019
Q2 | $53.2M | Sell |
643,882
-86,202
| -12% | -$6.76M | 0.02% | 687 |
|
|
2019
Q1 | $59M | Buy |
730,084
+584,498
| +401% | +$46.1M | 0.03% | 611 |
|
|
2018
Q4 | $11.1M | Sell |
145,586
-1,043,266
| -88% | -$81.5M | 0.01% | 1788 |
|
|
2018
Q3 | $94.1M | Sell |
1,188,852
-21,848
| -2% | -$1.65M | 0.04% | 440 |
|
|
2018
Q2 | $85M | Buy |
1,210,700
+1,089,036
| +895% | +$78.3M | 0.04% | 433 |
|
|
2018
Q1 | $8.51M | Buy |
121,664
+107,403
| +753% | +$7.44M | ﹤0.01% | 1889 |
|
|
2017
Q4 | $990K | Sell |
14,261
-298,307
| -95% | -$20.1M | ﹤0.01% | 4671 |
|
|
2017
Q3 | $21.2M | Buy |
312,568
+253,933
| +433% | +$16M | 0.02% | 1032 |
|
|
2017
Q2 | $4M | Sell |
58,635
-422
| -0.7% | -$27.6K | ﹤0.01% | 2357 |
|
|
2017
Q1 | $3.68M | Sell |
59,057
-178,370
| -75% | -$10.4M | ﹤0.01% | 2366 |
|
|
2016
Q4 | $13M | Buy |
237,427
+83,766
| +55% | +$4.76M | 0.01% | 1168 |
|
|
2016
Q3 | $10.1M | Buy |
153,661
+67,019
| +77% | +$4.38M | 0.01% | 1347 |
|
|
2016
Q2 | $5.23M | Sell |
86,642
-383,317
| -82% | -$22.3M | 0.01% | 1784 |
|
|
2016
Q1 | $26.5M | Buy |
+469,959
| New | +$28.2M | 0.03% | 585 |
|
|
2015
Q4 | – | Sell |
-159,789
| Closed | -$10.2M | – | 8711 |
|
|
2015
Q3 | $10.2M | Sell |
159,789
-173,913
| -52% | -$11.4M | 0.01% | 1349 |
|
|
2015
Q2 | $21.3M | Buy |
333,702
+127,450
| +62% | +$8.73M | 0.02% | 959 |
|
|
2015
Q1 | $14.1M | Buy |
206,252
+113,920
| +123% | +$7.92M | 0.01% | 1199 |
|
|
2014
Q4 | $6.5M | Sell |
92,332
-56,371
| -38% | -$4.04M | 0.01% | 1747 |
|
|
2014
Q3 | $10.6M | Buy |
148,703
+51,187
| +52% | +$3.75M | 0.01% | 1316 |
|
|
2014
Q2 | $7.25M | Buy |
97,516
+87,881
| +912% | +$6.35M | 0.01% | 1528 |
|
|
2014
Q1 | $625K | Sell |
9,635
-73,502
| -88% | -$4.75M | ﹤0.01% | 4035 |
|
|
2013
Q4 | $4.94M | Buy |
+83,137
| New | +$4.52M | 0.01% | 1700 |
|
|
2013
Q3 | – | Sell |
-246,477
| Closed | -$11.7M | – | 6717 |
|
|
2013
Q2 | $11.7M | Buy |
+246,477
| New | +$12.6M | 0.02% | 971 |
|
Other funds holding AZN
IA
VCM
VAM
Citadel Advisors's AZN Position: Q1 2026 in Review
Citadel Advisors increased its AstraZeneca (AZN) stake by 345% in Q1 2026, buying an estimated $280M and bringing the position to 1,869,793 shares worth $369M. The position accounts for 0.06% of the portfolio, ranked #251.
Citadel Advisors first reported a position in AZN in Q2 2013 and has held it in 50 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- Citadel Advisors held 1,869,793 shares of AstraZeneca worth $369M as of Q1 2026.
- Citadel Advisors bought 1,449,726 AstraZeneca shares in Q1 2026, an estimated $280M.
- AstraZeneca made up 0.06% of Citadel Advisors's portfolio in Q1 2026, its #251 holding.
- Citadel Advisors first reported a position in AstraZeneca in Q2 2013 and has held it in 50 quarters since.
- 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.